BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 36609218)

  • 1. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
    Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
    Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing.
    Xu L; Yin L; Qi Y; Tan X; Gao M; Peng J
    Acta Pharm Sin B; 2021 Oct; 11(10):3150-3164. PubMed ID: 34729306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early evolutionary divergence between papillary and anaplastic thyroid cancers.
    Capdevila J; Mayor R; Mancuso FM; Iglesias C; Caratù G; Matos I; Zafón C; Hernando J; Petit A; Nuciforo P; Cameselle-Teijeiro JM; Álvarez C; Recio JA; Tabernero J; Matias-Guiu X; Vivancos A; Seoane J
    Ann Oncol; 2018 Jun; 29(6):1454-1460. PubMed ID: 29648575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations.
    Wu P; Li T; Li R; Jia L; Zhu P; Liu Y; Chen Q; Tang D; Yu Y; Li C
    Nat Commun; 2017 Dec; 8(1):1937. PubMed ID: 29203764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines.
    Woodward EL; Biloglav A; Ravi N; Yang M; Ekblad L; Wennerberg J; Paulsson K
    Endocr Relat Cancer; 2017 May; 24(5):209-220. PubMed ID: 28235956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.
    Weinberger P; Ponny SR; Xu H; Bai S; Smallridge R; Copland J; Sharma A
    Thyroid; 2017 Feb; 27(2):236-252. PubMed ID: 27796151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
    Vanden Borre P; Schrock AB; Anderson PM; Morris JC; Heilmann AM; Holmes O; Wang K; Johnson A; Waguespack SG; Ou SI; Khan S; Fung KM; Stephens PJ; Erlich RL; Miller VA; Ross JS; Ali SM
    Oncologist; 2017 Mar; 22(3):255-263. PubMed ID: 28209747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
    Landa I; Ibrahimpasic T; Boucai L; Sinha R; Knauf JA; Shah RH; Dogan S; Ricarte-Filho JC; Krishnamoorthy GP; Xu B; Schultz N; Berger MF; Sander C; Taylor BS; Ghossein R; Ganly I; Fagin JA
    J Clin Invest; 2016 Mar; 126(3):1052-66. PubMed ID: 26878173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
    Duan H; Li Y; Hu P; Gao J; Ying J; Xu W; Zhao D; Wang Z; Ye J; Lizaso A; He Y; Wu H; Liang Z
    Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5C analysis of the Epidermal Differentiation Complex locus reveals distinct chromatin interaction networks between gene-rich and gene-poor TADs in skin epithelial cells.
    Poterlowicz K; Yarker JL; Malashchuk I; Lajoie BR; Mardaryev AN; Gdula MR; Sharov AA; Kohwi-Shigematsu T; Botchkarev VA; Fessing MY
    PLoS Genet; 2017 Sep; 13(9):e1006966. PubMed ID: 28863138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
    Zhang L; Zhang J; Li S; Zhang Y; Liu Y; Dong J; Zhao W; Yu B; Wang H; Liu J
    RNA Biol; 2021 Apr; 18(4):547-562. PubMed ID: 32951513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.
    Panebianco F; Nikitski AV; Nikiforova MN; Nikiforov YE
    Cancer Med; 2019 Oct; 8(13):5831-5839. PubMed ID: 31408918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area.
    Jeon MJ; Chun SM; Kim D; Kwon H; Jang EK; Kim TY; Kim WB; Shong YK; Jang SJ; Song DE; Kim WG
    Thyroid; 2016 May; 26(5):683-90. PubMed ID: 26980298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch.
    Hébrant A; Dom G; Dewaele M; Andry G; Trésallet C; Leteurtre E; Dumont JE; Maenhaut C
    PLoS One; 2012; 7(10):e37807. PubMed ID: 23115614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of new chromatin domains determines pathogenicity of genomic duplications.
    Franke M; Ibrahim DM; Andrey G; Schwarzer W; Heinrich V; Schöpflin R; Kraft K; Kempfer R; Jerković I; Chan WL; Spielmann M; Timmermann B; Wittler L; Kurth I; Cambiaso P; Zuffardi O; Houge G; Lambie L; Brancati F; Pombo A; Vingron M; Spitz F; Mundlos S
    Nature; 2016 Oct; 538(7624):265-269. PubMed ID: 27706140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differences of regulatory networks between papillary and anaplastic thyroid carcinoma: an integrative transcriptomics study.
    Pan Z; Li L; Qian Y; Ge X; Hu X; Zhang Y; Ge M; Huang P
    Cancer Biol Ther; 2020 Sep; 21(9):853-862. PubMed ID: 32887540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
    Kunstman JW; Juhlin CC; Goh G; Brown TC; Stenman A; Healy JM; Rubinstein JC; Choi M; Kiss N; Nelson-Williams C; Mane S; Rimm DL; Prasad ML; Höög A; Zedenius J; Larsson C; Korah R; Lifton RP; Carling T
    Hum Mol Genet; 2015 Apr; 24(8):2318-29. PubMed ID: 25576899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of common structural variants on 3D chromatin structure.
    Shanta O; Noor A; ; Sebat J
    BMC Genomics; 2020 Jan; 21(1):95. PubMed ID: 32000688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel somatic alterations underlie Chinese papillary thyroid carcinoma.
    Yang C; Xu W; Gong J; Liu Z; Cui D
    Cancer Biomark; 2020; 27(4):445-460. PubMed ID: 32065787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.